Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/2011 → 31/01/2015 |
Collaborative partners
- King's College London (lead)
- KCH King's College Hospital NHS Foundation Trust
Funding
- Medical University of Vienna: £2,640.00
A double blind, randomized, placebo controlled, multi centre trial of anti-TNFa chimeric monoclonal antibody (Infliximab, Remicade) in combination with methotrexate in patients with very early inflammatory arthritis (DINORA)
- Scott, David (Primary Investigator)
Project: Research